SEARCH RESULTS

330059 RESULTS

Affitope AD02

THERAPEUTICS AFFiRiS AG Immunotherapy (active) Amyloid-Related A Phase 1 study conducted in Austria tested subcutaneous AD02 alone and with aluminium hydroxide adjuvant in 24 patients with mild to moderate Alzheimer's disease. It showed a favorable safety and tol

AF 102B

THERAPEUTICS SnowBrand Pharmaceuticals, Inc. cevimeline HCL Evoxac™ Small Molecule Cholinergic System Hypo-activity of the cholinergic system is associated AD and cognitive decline. Two different strategies have been used to increase cholinergic acitvity  in the AD br

Acetyl-l-carnitine HCI

THERAPEUTICS Sigma-Tau Pharmaceuticals ALCAR Supplement, Dietary Other ALCAR has been found to be cardioprotective as well as neuroprotective in a number of disease models (hypoxia/ischmia, traumatic brain injury) (Zanelli et al., 2005). Beneficial effects of ALCAR on

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE